Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) is now available.
Shanghai MicroPort MedBot (Group) Co., Ltd. announced the convening of its Annual General Meeting on June 25, 2025, to discuss and approve several key resolutions. These include the approval of the 2024 Annual Report, the appointment of new directors and auditors, and the granting of mandates to issue additional shares and buy back shares. These resolutions are expected to impact the company’s capital structure and operational strategies, potentially influencing its market positioning and shareholder value.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the medical technology industry. The company is involved in the development and manufacturing of medical robots and related technologies, aiming to enhance surgical precision and efficiency.
Average Trading Volume: 9,619,595
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.05B
Find detailed analytics on 2252 stock on TipRanks’ Stock Analysis page.